These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 794616

  • 1. [Clinical experience with the oral liver-therapeutic agent Hepavis].
    Bayazid A, Gerhard W.
    Med Welt; 1976 Nov 12; 27(46):2248-9. PubMed ID: 794616
    [No Abstract] [Full Text] [Related]

  • 2. [Reflections on medicamentous liver-therapy. Hepavis in medical practice].
    Wegener W.
    Med Monatsschr; 1977 Jul 12; 31(7):328-30. PubMed ID: 904570
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical experience report on Hepavis].
    Menninger U, Menninger W.
    Med Welt; 1980 Oct 17; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment with Hepavis, a new cholerectically-active hepaticum. Experiences from an internal medicine profemoral practice].
    Stuchlik S.
    Med Monatsschr; 1977 Nov 17; 31(11):524-6. PubMed ID: 927326
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of alcoholic toxic fatty liver. A placebo-controlled trial with hepavis (author's transl)].
    Deynet G, Reimer F.
    MMW Munch Med Wochenschr; 1979 Jun 15; 121(24):831-2. PubMed ID: 111085
    [Abstract] [Full Text] [Related]

  • 6. [Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?].
    Odegaard S, Busch D.
    Z Gastroenterol; 1989 Feb 15; 27(2):91-3. PubMed ID: 2658394
    [Abstract] [Full Text] [Related]

  • 7. [Repair, regeneration and metabolism of liver cells: a clinical report].
    Blasy J.
    ZFA (Stuttgart); 1979 Apr 30; 55(12):787-91. PubMed ID: 375610
    [No Abstract] [Full Text] [Related]

  • 8. [Drug therapy of liver diseases with Hepatofalk].
    Hirsch W, Smerlings H.
    Ther Ggw; 1976 Oct 30; 115(10):1719-54. PubMed ID: 136762
    [No Abstract] [Full Text] [Related]

  • 9. [Controlled clinical trial of a new combination of phosphorylcholine, homocysteine-gamma-thiolactone and vitamin B 12 in the parenteral treatment of chronic hepatopathies].
    Bandini S, Monteforte S.
    Clin Ter; 1974 Jun 30; 69(6):549-60. PubMed ID: 4845637
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
    Mariani B, Marchioni GF, Capitolo S.
    Minerva Med; 1974 Aug 04; 65(57):2977-89. PubMed ID: 4603931
    [No Abstract] [Full Text] [Related]

  • 11. [The effect and tolerance of a gall-enzyme preparation].
    Gross W, Kaiser HJ.
    Med Welt; 1978 Jan 27; 29(4):144-9. PubMed ID: 345040
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical trials of Aicamin].
    Azzena D, Trasciatti S, Capuzzo R.
    Minerva Dietol Gastroenterol; 1977 Jan 27; 23(4):345-51. PubMed ID: 349423
    [No Abstract] [Full Text] [Related]

  • 13. [Disorders of vitamin B12 absorption in exocrine pancreatic insufficiency. Substitution treatment using Gillazym].
    Herzfeld U, Kaess H.
    Med Welt; 1973 Jan 12; 24(2):48-50. PubMed ID: 4610314
    [No Abstract] [Full Text] [Related]

  • 14. [Current views on the liver-protective therapy: clinical evaluation of 4-amino-5-carbamide imidazole 2,4-dihydroxy-6-pyrimidine carbonate].
    Tàmmaro AE, Bonaccorso O.
    Clin Ter; 1975 Oct 31; 75(2):141-51. PubMed ID: 1227763
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of a new preparation with liver-protective and anti-anemic action].
    Cairella M.
    Clin Ter; 1966 Dec 31; 39(6):567-76. PubMed ID: 4232883
    [No Abstract] [Full Text] [Related]

  • 16. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M, Ancona A, Palmieri R, Palmieri G, Zambruno E.
    Clin Ter; 1980 Dec 31; 95(6):637-54. PubMed ID: 7011665
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical trial of a new hepatoprotective preparation].
    Azzena D.
    Clin Ter; 1972 Jan 31; 60(2):143-8. PubMed ID: 5015349
    [No Abstract] [Full Text] [Related]

  • 18. [The treatment of vascular diseases with a magnesium containing drug (Progresin)].
    Straube G.
    Z Allgemeinmed; 1975 Mar 27; 51(9):450-5. PubMed ID: 1163068
    [No Abstract] [Full Text] [Related]

  • 19. [Therapeutic effect of a preparation of total liver extract, cyanocobalamin and amino acids of the Krebs cycle, in acute and chronic liver diseases].
    Pignattari S, Sarti F, Toscano S, Dal Monte PR.
    Minerva Med; 1972 Jul 11; 63(53):2861-72. PubMed ID: 5049878
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of a new preparation with digestive-antispastic activity].
    De Benedictis N, Ferro GF.
    Minerva Gastroenterol; 1972 Jul 11; 18(1):35-44. PubMed ID: 4614109
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.